Evidence map›Paper›PMID 31178479›Full record

ArticleInternal medicine (Tokyo, Japan)2019

Novel VRK1 Mutations in a Patient with Childhood-onset Motor Neuron Disease.

Genpei Yamaura, Yuichi Higashiyama, Kaori Kusama, Misako Kunii, Kenichi Tanaka, Shigeru Koyano, Mitsuko Nakashima, Yoshinori Tsurusaki, Noriko Miyake, Hirotomo Saitsu and 5 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. NovelNeurology. Genetics · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Genpei YamauraDepartment of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan.
Yuichi HigashiyamaDepartment of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan.
Kaori KusamaDepartment of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan.
Misako KuniiDepartment of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan.
Kenichi TanakaDepartment of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan.
Shigeru KoyanoDepartment of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan.
Mitsuko NakashimaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Japan.
Yoshinori TsurusakiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Japan.
Noriko MiyakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Japan.
Hirotomo SaitsuDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Japan.
Yukiko IwahashiDepartment of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan.
Hideto JokiDepartment of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan.
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Japan.
Hiroshi DoiDepartment of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan.
Fumiaki TanakaDepartment of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan.
Yokohama City University · JPHamamatsu University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 24-year-old Japanese man exhibited slowly progressive gait disturbance from childhood to young adulthood. Physical and physiological examinations showed the involvement of both upper and lower motor neurons, fulfilling the diagnostic criteria for amyotrophic lateral sclerosis (ALS). Mild cognitive impairment and subclinical sensory involvement were also observed. A genetic analysis revealed novel compound heterozygous mutations, c.767C>T (p.Thr256Ile) and c.800A>G (p.Asp267Gly), in the vaccinia-related kinase 1 gene (VRK1). This is the first report of a Japanese patient with a motor neuron disease phenotype caused by VRK1 mutations. This diagnosis should be considered in atypical cases of juvenile-onset and slowly progressive types of motor neuron disease.

Indexed as

Amyotrophic Lateral SclerosisCognitive DysfunctionGenetic TestingHeterozygoteHumansIntracellular Signaling Peptides and ProteinsMaleMotor Neuron DiseaseMutationNeural ConductionPhenotypeProtein Serine-Threonine KinasesYoung AdultIntracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesVRK1 protein, humanamyotrophic lateral sclerosischildhood-onsetmotor neuron diseaseVRK1

Identifiers

PMID31178479
PMCPMC6794182
OpenAlexW2953157298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.